Rare diseases
Investigational molecules
Locations
474 conditions with trials, the busiest first
1 133 trials across Europe, recruiting first
Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Ulcerative Colitis
AustriaStudy on Bintrafusp Alfa with Chemoradiation for Patients with Esophageal Squamous Cell Carcinoma
The NetherlandsStudy on Tezepelumab for Symptom Relief in Patients Aged 12-80 with Eosinophilic Esophagitis
AustriaLong-term study of upadacitinib tablets for adults with Crohn's disease
DenmarkStudy comparing 177Lu-edotreotide versus everolimus in patients with inoperable progressive neuroendocrine tumors of gastroenteric or pancreatic origin
AustriaStudy on Long-term Safety of VX-121, Tezacaftor, and Deutivacaftor in Patients with Cystic Fibrosis
AustriaStudy of Tofacitinib for Children with Moderate to Severe Ulcerative Colitis
BelgiumStudy on BP1.7881 for Adults with Eosinophilic Esophagitis
FranceStudy on EO4010 Vaccine with Nivolumab and Bevacizumab for Patients with Metastatic Colorectal Cancer Who Have Already Received Treatment
FranceStudy on the Effectiveness and Safety of Iptacopan for Adults with Atypical Hemolytic Uremic Syndrome Not Previously Treated with Complement Inhibitors
AustriaStudy on Aspirin's Effect on Recurrence and Survival in Patients with Non-Metastatic Breast, Colon, Rectal, Stomach, Esophageal, and Prostate Cancer
IrelandLong-Term Study of Ustekinumab for Patients with Crohn's Disease Who Previously Lost Response to Treatment
BelgiumThe therapies tested most often in Gastrointestinal disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
